ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $139,000 | -40.1% | 213,560 | +0.3% | 0.00% | – |
| Q4 2021 | $232,000 | -44.5% | 212,860 | -7.4% | 0.00% | – |
| Q3 2021 | $418,000 | -34.1% | 229,760 | -4.4% | 0.00% | – |
| Q2 2021 | $634,000 | -19.1% | 240,228 | +10.3% | 0.00% | – |
| Q1 2021 | $784,000 | +75.8% | 217,728 | +23.0% | 0.00% | – |
| Q4 2020 | $446,000 | -14.7% | 177,028 | -14.7% | 0.00% | – |
| Q3 2020 | $523,000 | -27.6% | 207,528 | -5.7% | 0.00% | – |
| Q2 2020 | $722,000 | +39.4% | 220,128 | +4.1% | 0.00% | – |
| Q1 2020 | $518,000 | -50.5% | 211,528 | -4.6% | 0.00% | -100.0% |
| Q4 2019 | $1,046,000 | +4.7% | 221,660 | -5.0% | 0.00% | 0.0% |
| Q3 2019 | $999,000 | -26.5% | 233,360 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,360,000 | +48.8% | 233,360 | -1.7% | 0.00% | 0.0% |
| Q1 2019 | $914,000 | +76.4% | 237,392 | -14.3% | 0.00% | – |
| Q4 2018 | $518,000 | -41.7% | 276,971 | -0.3% | 0.00% | -100.0% |
| Q3 2018 | $889,000 | +25.7% | 277,830 | +18.6% | 0.00% | – |
| Q2 2018 | $707,000 | -7.3% | 234,219 | +20.4% | 0.00% | -100.0% |
| Q1 2018 | $763,000 | -5.2% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $805,000 | -32.6% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,194,000 | -1.3% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,210,000 | -1.9% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,233,000 | +18.4% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,041,000 | -4.9% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,095,000 | +2.5% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,068,000 | -26.0% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,443,000 | -9.6% | 194,519 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $1,596,000 | -9.2% | 192,019 | -1.5% | 0.00% | -50.0% |
| Q3 2015 | $1,757,000 | -25.0% | 194,988 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,342,000 | +78.1% | 195,197 | +59.9% | 0.00% | +100.0% |
| Q1 2015 | $1,315,000 | +167.3% | 122,100 | +25.9% | 0.00% | – |
| Q4 2014 | $492,000 | +92.2% | 97,000 | 0.0% | 0.00% | – |
| Q3 2014 | $256,000 | -34.5% | 97,000 | 0.0% | 0.00% | – |
| Q2 2014 | $391,000 | -3.0% | 97,000 | +10.2% | 0.00% | – |
| Q1 2014 | $403,000 | -9.4% | 88,017 | -14.1% | 0.00% | – |
| Q4 2013 | $445,000 | +9.9% | 102,515 | 0.0% | 0.00% | – |
| Q3 2013 | $405,000 | +66.7% | 102,515 | -11.5% | 0.00% | – |
| Q2 2013 | $243,000 | – | 115,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|